EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools

Marco Murgiano iD, Bianca Bartocci, Pierluigi Puca iD, Federica di Vincenzo iD, Angelo Del Gaudio, Alfredo Papa, Giovanni Cammarota, Antonio Gasbarrini iD, Franco Scaldaferri iD, Loris Riccardo Lopetuso iD

International Journal of Molecular Sciences · 27.03.2025 · 26 (7) · 3059

DOI: 10.3390/ijms26073059 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.03.2025. Verfasst von Marco Murgiano und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 246 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders primarily comprising two main conditions: ulcerative colitis and Crohn’s disease. The gut microbiota’s role in driving inflammation in IBD has garnered significant attention, yet the precise mechanisms through which the microbiota influences IBD pathogenesis remain largely unclear. Given the limited therapeutic options for IBD, alternative microbiota-targeted therapies—including prebiotics, probiotics, postbiotics, and symbiotics—have been proposed. While these approaches have shown promising results, microbiota modulation is still mainly considered an adjunct therapy to conventional treatments, with a demonstrated impact on patients’ quality of life. Fecal microbiota transplantation (FMT), already approved for treating Clostridioides difficile infection, represents the first in a series of innovative microbiota-based therapies under investigation. Microbial biotherapeutics are emerging as personalized and cutting-edge tools for IBD management, encompassing next-generation probiotics, bacterial consortia, bacteriophages, engineered probiotics, direct metabolic pathway modulation, and nanotherapeutics. This review explores microbial modulation as a therapeutic strategy for IBDs, highlighting current approaches and examining promising tools under development to better understand their potential clinical applications in managing intestinal inflammatory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeInflammatory Bowel DiseasesHumansFecal Microbiota TransplantationProbioticsAnimalsPrebiotics

Stichwörter der Autor:innen

dysbiosisfecal microbiota transplantationgut microbiotainflammatory bowel diseasemicrobial biotherapeuticsmicrobiota modulationprobiotics

Substanzen

Prebiotics

Autor:innen und Institutionen

  • Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
  • Medicina Interna e Gastroenterologia, CEMAD Centro Malattie dell'Apparato Digerente, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario Gemelli IRCCS, 00168 Rome, Italy.
  • Dipartimento di Scienze della Vita, della Salute e delle Professioni Sanitarie, Università degli Studi Link, 00165 Rome, Italy.

ORCID-Profile: Marco Murgiano, Pierluigi Puca, Federica di Vincenzo, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso

Zitieren

APA

Murgiano, M., Bartocci, B., Puca, P., di Vincenzo, F., Del Gaudio, A., Papa, A., Cammarota, G., Gasbarrini, A., Scaldaferri, F., & Lopetuso, L. R. (2025). Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools. International Journal of Molecular Sciences, 26(7), 3059. https://doi.org/10.3390/ijms26073059

Vancouver

Murgiano M, Bartocci B, Puca P, di Vincenzo F, Del Gaudio A, Papa A, et al. Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools. International Journal of Molecular Sciences. 2025;26(7):3059. doi:10.3390/ijms26073059

BibTeX
@article{Murgiano2025,
  author = {Murgiano, Marco and Bartocci, Bianca and Puca, Pierluigi and di Vincenzo, Federica and Del Gaudio, Angelo and Papa, Alfredo and Cammarota, Giovanni and Gasbarrini, Antonio and Scaldaferri, Franco and Lopetuso, Loris Riccardo},
  title = {Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {7},
  pages = {3059},
  doi = {10.3390/ijms26073059}
}
Kostenlos starten →